LUCY RIDEOUT: Open Payments
NPI 1073053351 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$532 in 24 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $532
Food & beverage: $532
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 8 | $212 |
| Alkermes, Inc. | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| ABBVIE INC. | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $18 |
| Bausch Health US, LLC | 1 | $15 |
Products named: FANAPT, ARISTADA, TRINTELLIX, REXULTI, VRAYLAR, Qelbree, ABILIFY ASIMTUFII, AUSTEDO XR.
Industry payments across OR — which companies pay providers there.
